MELOXICAM
| Brand name | QMIIZ ODT |
|---|---|
| Active ingredient | MELOXICAM |
| Strength | 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | October 2018 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8545879 | August 2030 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.